Evidence map›Paper›PMID 24925985›Full record

Trial reportThe British journal of psychiatry : the journal of mental science2015

Gains in employment status following antidepressant medication or cognitive therapy for depression.

Jay C Fournier, Robert J DeRubeis, Jay Amsterdam, Richard C Shelton, Steven D Hollon

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of psychiatry : the journal of mental science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Interventions to improve return to work in depressed people.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Moderation, mediation, and moderated mediation.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Making Evidence-Based Psychotherapy More Accessible in Canada.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2016
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Jay C FournierJay C. Fournier, PhD, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Robert J. DeRubeis, PhD, Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania; Jay Amsterdam, MD, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Richard C. Shelton, MD, Department of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama; Steven D. Hollon, PhD, Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA.
Robert J DeRubeisJay C. Fournier, PhD, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Robert J. DeRubeis, PhD, Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania; Jay Amsterdam, MD, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Richard C. Shelton, MD, Department of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama; Steven D. Hollon, PhD, Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA.
Jay AmsterdamJay C. Fournier, PhD, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Robert J. DeRubeis, PhD, Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania; Jay Amsterdam, MD, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Richard C. Shelton, MD, Department of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama; Steven D. Hollon, PhD, Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA.
Richard C SheltonJay C. Fournier, PhD, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Robert J. DeRubeis, PhD, Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania; Jay Amsterdam, MD, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Richard C. Shelton, MD, Department of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama; Steven D. Hollon, PhD, Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA.
Steven D HollonJay C. Fournier, PhD, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Robert J. DeRubeis, PhD, Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania; Jay Amsterdam, MD, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Richard C. Shelton, MD, Department of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama; Steven D. Hollon, PhD, Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA.
Robert Morris University · USUniversity of Alabama at Birmingham · USUniversity of Pennsylvania · USUniversity of Pittsburgh · US

Funding

Treatment of Bipolar Type II Major DepressionR01MH060353 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI DERUBEIS, ROBERT J · 2001 to 2011
$3.9M
1/2-Prevention of Relapse & Recurrence of Bipolar DepressionR01MH080097 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI DERUBEIS, ROBERT J · 2009 to 2013
$2.0M
Long-Term Chamomile Therapy of Generalized Anxiety DisorderR01AT005074 · NCCIH · UNIVERSITY OF PENNSYLVANIA · PI MAO, JUN J · 2009 to 2013
$1.9M
Neural Markers of Individual Difference in Emotion Regulation in Depressed AdultsK23MH097889 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FOURNIER, JAY C · 2013 to 2017
$786k
Effect of Psychotherapy on Brain Serotonin ActivityR34MH077580 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI AMSTERDAM, JAY D · 2008 to 2010
$638k
COGNITIVE THERAPY AND PHARMACOTHERAPY FOR DEPRESSIONR10MH055877 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI DERUBEIS, ROBERT J · 1996 to 2000
$314k
COGNITIVE THERAPY AND PHARMACOTHERAPY FOR DEPRESSIONR10MH055875 · NIMH · VANDERBILT UNIVERSITY · PI HOLLON, STEVEN D · 1996 to 2000
$231k
NCCIH NIH HHS AT005074NCCIH NIH HHS R01 AT005074NIMH NIH HHS K23 MH097889NIMH NIH HHS MH060353NIMH NIH HHS MH06099NIMH NIH HHS MH077580NIMH NIH HHS MH080097NIMH NIH HHS MH097889NIMH NIH HHS R01 MH060353NIMH NIH HHS R01 MH080097NIMH NIH HHS R10 MH055875NIMH NIH HHS R10 MH055877NIMH NIH HHS R34 MH077580
6 · The paper itself

Abstract

backgroundDepression can adversely affect employment status.

aimsTo examine whether there is a relative advantage of cognitive therapy or antidepressant medication in improving employment status following treatment, using data from a previously reported trial.

methodRandom assignment to cognitive therapy (n = 48) or the selective serotonin reuptake inhibitor paroxetine (n = 93) for 4 months; treatment responders were followed for up to 24 months. Differential effects of treatment on employment status were examined.

resultsAt the end of 28 months, cognitive therapy led to higher rates of full-time employment (88.9%) than did antidepressant medication among treatment responders (70.8%), χ(2) 1 = 5.78, P = 0.02, odds ratio (OR) = 5.66, 95% CI 1.16-27.69. In the shorter-term, the main effect of treatment on employment status was not significant following acute treatment (χ(2) 1 = 1.74, P = 0.19, OR = 1.77, 95% CI 0.75-4.17); however, we observed a site×treatment interaction (χ(2) 1 = 6.87, P = 0.009) whereby cognitive therapy led to a higher rate of full-time employment at one site but not at the other.

conclusionsCognitive therapy may produce greater improvements in employment v. medication, particularly over the longer term.

Indexed as

Cognitive Behavioral TherapyAntidepressive AgentsDepressionEmploymentFollow-Up StudiesHumansMajor Depressive DisorderOdds RatioParoxetineSelective Serotonin Reuptake InhibitorsTreatment OutcomeAntidepressive AgentsParoxetineSelective Serotonin Reuptake Inhibitors

Identifiers

PMID24925985
PMCPMC4264990
OpenAlexW1993520339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.